Bayer wins first court case in Roundup child cancer battle

October 6, 2021
Medical Communications, Research and Development

Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …

Transgene and BioInvent to present oncolytic virus data at SITC 2021

October 5, 2021
Manufacturing and Production

Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …

6206572255_438e12011d_c

AstraZeneca requests emergency authorisation for COVID-19 drug

October 5, 2021
Manufacturing and Production

AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …

Kintor begins Phase III trial of proxalutamide for COVID patients in US

October 5, 2021
Manufacturing and Production

Chinese clinical-stage drug developer, Kintor Pharmaceutical Ltd, has announced the initiation of the Phase III clinical trial of proxalutamide for …

Brain implant can lift severe depression, study finds

October 5, 2021
Manufacturing and Production, Research and Development

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …

NICE recommends first new sickle cell disease treatment in 20 years

October 5, 2021
Manufacturing and Production, Medical Communications, Research and Development

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …

1109181692_a148e995c4_c

AlzeCure’s Alzheimer project initiates Phase I study

October 4, 2021
Sales and Marketing

Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …

SEED invests in CBD brand business

October 4, 2021
Sales and Marketing

SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …

Bayer Phase III trial results prove positive for diabetes patients

October 4, 2021
Sales and Marketing

Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to …

Eli Lilly and India’s Cipla enter deal on diabetes treatments

October 4, 2021
Business Services, Sales and Marketing

Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling …

az

FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu

October 4, 2021
Research and Development, Sales and Marketing

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …

Faron raises over €10mln to support key drug candidates

October 1, 2021
Medical Communications

Clinical stage biopharmaceutical company, Faron, has raised €10.5mln through a placing of new shares backed by the European Innovation Council …

Delta variant found to be common in children across US

October 1, 2021
Medical Communications

School-aged children across the US are being exposed to the increasingly prevalent Delta variant of COVID-19. This is linked to …

New Gyros kit supports cell and gene therapy

October 1, 2021
Medical Communications

Gyros Protein Technologies, leading provider of peptide synthesisers and reagents, has introduced the Gyrolab® AAV9 Titer Kit to support AAV-based …

Takeda: Stainless steel COVID vaccine contamination due to human error

October 1, 2021
Medical Communications

Takeda has said that “human error” led to metal contaminants being present in Moderna’s COVID-19 vaccine doses, which caused around …

GSK and Merck KGaA end collaboration on cancer drug hopeful

October 1, 2021
Medical Communications

GSK and German based Merck KGaA announced on Thursday that they have ended their collaboration on cancer treatment bintrafusp alfa, …

EADV reveals vaccine hesitancy in psoriasis patients

September 30, 2021
Business Services

Research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress has revealed that psoriasis and psoriatic arthritic …

Nanoform granted funding to tackle global health challenges

September 30, 2021
Business Services

Innovative nanoparticle medicine company, Nanoform, has announced that proof of concept studies will receive funding from the Bill & Melinda …

MSD pioneers gender-neutral HPV vaccine in India

September 30, 2021
Business Services

MSD Pharmaceuticals has announced the launch of India’s first gender-neutral Human Papillomavirus (HPV) vaccine, according to ABP Live. The aim …

Study finds coming off antidepressants may not cause relapse

September 30, 2021

Researchers from the universities of York, Southampton, and Bristol, UCL, and McMaster University in Canada, have been investigating the impacts …

The Gateway to Local Adoption Series

Latest content